Overcoming Barriers to Cancer Prevention Research in Nova Scotia
GrantID: 76336
Grant Funding Amount Low: $200,000
Deadline: Ongoing
Grant Amount High: $275,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Health & Medical grants, Higher Education grants, Individual grants, Research & Evaluation grants, Science, Technology Research & Development grants.
Grant Overview
Nova Scotia’s population density of 17.5 persons per square kilometer masks sharp intra-provincial variation: Halifax Regional Municipality accounts for 45 percent of residents while five eastern counties average 4.2 persons per square kilometer. This split produces differential cancer-stage-at-diagnosis patterns documented in the Nova Scotia Cancer Registry 2016–2022, with stage III–IV presentations 11 percentage points higher outside the Halifax commuter shed.
Dalhousie University’s Beatrice Hunter Cancer Research Institute maintains the province’s only dedicated cancer biobank, holding 14,000 annotated specimens as of 2023. Access requires a completed material transfer agreement and proof that the requesting investigator’s institution maintains CLIA-equivalent certification for any downstream assays. These procedural layers add 8–11 weeks to project startup timelines.
The grant allows direct-cost budgets reaching $275,000 across one to three years for basic or translational cancer research. Applications must reference the Nova Scotia Health Authority’s single central ethics platform and include a timetable showing when the first 50 specimens will be released from the biobank. Projects that propose secondary use of the Atlantic PATH cohort’s environmental exposure data linked to cancer outcomes are flagged for expedited administrative review.
In contrast to New Brunswick filings, Nova Scotia submissions must demonstrate that any proposed environmental exposure analysis will draw on the province’s 1 km-resolution air-quality monitoring grid rather than relying solely on postal-code proxies.
Eligible Regions
Interests
Eligible Requirements
Related Grants
$50,000 Grants for Breast Cancer Research Projects Worldwide
Research funding of $50,000 USD for up to one year to support innovative scientific projects related...
TGP Grant ID:
76337
Research Grants for Innovative ALS Studies and Clinical Trials
This grant opportunity supports scientific research focused on ALS (amyotrophic lateral sclerosis) a...
TGP Grant ID:
76344
Medical Research Grant Opportunities for Global Institutions
These funding opportunities support research efforts focused on improving health outcomes through sc...
TGP Grant ID:
76403
$50,000 Grants for Breast Cancer Research Projects Worldwide
Deadline :
Ongoing
Funding Amount:
$0
Research funding of $50,000 USD for up to one year to support innovative scientific projects related to a specific type of breast cancer subtype. The...
TGP Grant ID:
76337
Research Grants for Innovative ALS Studies and Clinical Trials
Deadline :
Ongoing
Funding Amount:
$0
This grant opportunity supports scientific research focused on ALS (amyotrophic lateral sclerosis) and is open to qualified investigators working at a...
TGP Grant ID:
76344
Medical Research Grant Opportunities for Global Institutions
Deadline :
Ongoing
Funding Amount:
$0
These funding opportunities support research efforts focused on improving health outcomes through scientific discovery and clinical advancement. Suppo...
TGP Grant ID:
76403